Expert Panel Debates Risks and Benefits of SSRI Use in Pregnancy
A 10-member panel, led by FDA Commissioner Marty Makary, recently discussed the use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy. The majority of the panelists argued against SSRI use during pregnancy due to potential risks such as altered fetal brain development and congenital cardiac malformations. However, leading medical organizations, including the American College of … Read more